Concepedia

Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials

Georg Griesinger, Bernadette Mannaerts, Claus Yding Andersen, Han Witjes, Efstratios M. Κolibianakis, Keith Gordon

Fertility and Sterility · 2013 · 142 citations · 28 references

DOIFull text

Open access

Concepts

References

28

Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles

Ernesto Bosch, Elena Labarta, Juana Crespo et al. · Human Reproduction · 2010 · 520 citations · Full text

, , +14

Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial

George F. Borm, Bernadette Mannaerts · Human Reproduction · 2000 · 376 citations · Full text

, , +16

Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome

Ernesto Bosch, Iván Valencia, Ernesto Escudero et al. · Fertility and Sterility · 2003 · 347 citations · Full text

, , +16

Serum progesterone level effects on the outcome of in vitro fertilization in patients with different ovarian response: an analysis of more than 10,000 cycles

Bei Xu, Li Zhou, Hanwang Zhang et al. · Fertility and Sterility · 2012 · 260 citations · Full text

, , +16

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

Human Reproduction · 2001 · 243 citations · Full text

, , +15